CL2022002326A1 - Intermedio útil para síntesis de inhibidor de sglt y método para preparar inhibidor de sglt - Google Patents
Intermedio útil para síntesis de inhibidor de sglt y método para preparar inhibidor de sgltInfo
- Publication number
- CL2022002326A1 CL2022002326A1 CL2022002326A CL2022002326A CL2022002326A1 CL 2022002326 A1 CL2022002326 A1 CL 2022002326A1 CL 2022002326 A CL2022002326 A CL 2022002326A CL 2022002326 A CL2022002326 A CL 2022002326A CL 2022002326 A1 CL2022002326 A1 CL 2022002326A1
- Authority
- CL
- Chile
- Prior art keywords
- chemical formula
- purification
- sglt inhibitor
- synthesis
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/02—Phosphorylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/06—Heterocyclic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La presente invención proporciona un producto intermedio útil para la síntesis de un inhibidor de SGLT y un método para preparar un inhibidor de SGLT usando el mismo. Según la presente invención, al desarrollar un compuesto de fórmula química 5 correspondiente a un producto intermedio novedoso, puede resolverse la dificultad de purificación con los procedimientos existentes, pueden satisfacerse los requisitos de calidad para sustancias relacionadas con una única etapa de purificación y puede resolverse el problema de control de calidad en cada etapa realizando varias etapas in situ. El método para sintetizar un compuesto de fórmula química 1 mediante el uso de un compuesto de fórmula química 5, según la presente invención, permite la purificación en la etapa de síntesis de un compuesto de fórmula química 5, resolviendo de ese modo los problemas de los procedimientos de síntesis existentes, en los que los requisitos de calidad para sustancias relacionadas eran difíciles de controlar etapa por etapa debido a un procedimiento continuo, y minimizando la cantidad de sustancias relacionadas en el producto final. Además, a medida que aumenta el número de etapas de purificación, el procedimiento puede simplificarse porque la purificación no se realiza necesariamente dos o más veces en una etapa como en la técnica anterior, maximizando de ese modo el rendimiento de producción de un derivado de difenilmetano según la fórmula química 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200024525 | 2020-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2022002326A1 true CL2022002326A1 (es) | 2023-02-10 |
Family
ID=77490302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2022002326A CL2022002326A1 (es) | 2020-02-27 | 2022-08-25 | Intermedio útil para síntesis de inhibidor de sglt y método para preparar inhibidor de sglt |
Country Status (13)
Country | Link |
---|---|
US (1) | US20230096670A1 (es) |
EP (1) | EP4112612A4 (es) |
JP (1) | JP7442663B2 (es) |
KR (1) | KR102572714B1 (es) |
CN (1) | CN115087649A (es) |
BR (1) | BR112022014762A2 (es) |
CA (1) | CA3169604A1 (es) |
CL (1) | CL2022002326A1 (es) |
CO (1) | CO2022011686A2 (es) |
EC (1) | ECSP22067279A (es) |
MX (1) | MX2022010220A (es) |
PE (1) | PE20221498A1 (es) |
WO (1) | WO2021172955A1 (es) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5530124A (en) * | 1994-06-30 | 1996-06-25 | The Dupont Merck Pharmaceutical Company | Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors |
ME02702B (me) * | 2008-08-22 | 2017-10-20 | Theracos Sub Llc | Postupci za pripremu inhibitora sgl t2 |
WO2012033390A2 (en) * | 2010-09-10 | 2012-03-15 | Green Cross Corporation | Novel thiophene derivative as sglt2 inhibitor and pharmaceutical composition comprising same |
WO2012165914A2 (en) * | 2011-06-01 | 2012-12-06 | Green Cross Corporation | Novel diphenylmethane derivatives as sglt2 inhibitors |
US9340521B2 (en) * | 2013-03-18 | 2016-05-17 | Green Cross Corporation | Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives |
US10174010B2 (en) * | 2014-03-19 | 2019-01-08 | Hangzhou Pushai Pharmaceutical Technology Co., Ltd. | Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof |
WO2016098016A1 (en) * | 2014-12-17 | 2016-06-23 | Dr. Reddy’S Laboratories Limited | Process for the preparation of sglt2 inhibitors |
ES2898336T3 (es) | 2016-06-17 | 2022-03-07 | Dae Woong Pharma | Derivado de difenilmetano en forma cristalina |
CN108530408A (zh) * | 2018-04-13 | 2018-09-14 | 海门慧聚药业有限公司 | 制备达格列净的方法 |
BR112021002523A2 (pt) * | 2018-08-13 | 2021-05-04 | Daewoong Pharmaceutical Co., Ltd. | método para preparar um composto |
-
2021
- 2021-02-26 MX MX2022010220A patent/MX2022010220A/es unknown
- 2021-02-26 CA CA3169604A patent/CA3169604A1/en active Pending
- 2021-02-26 US US17/799,054 patent/US20230096670A1/en active Pending
- 2021-02-26 CN CN202180013608.6A patent/CN115087649A/zh active Pending
- 2021-02-26 JP JP2022550984A patent/JP7442663B2/ja active Active
- 2021-02-26 PE PE2022001824A patent/PE20221498A1/es unknown
- 2021-02-26 EP EP21761658.0A patent/EP4112612A4/en active Pending
- 2021-02-26 WO PCT/KR2021/002507 patent/WO2021172955A1/ko active Application Filing
- 2021-02-26 BR BR112022014762A patent/BR112022014762A2/pt unknown
- 2021-02-26 KR KR1020210026669A patent/KR102572714B1/ko active IP Right Grant
-
2022
- 2022-08-19 CO CONC2022/0011686A patent/CO2022011686A2/es unknown
- 2022-08-25 CL CL2022002326A patent/CL2022002326A1/es unknown
- 2022-08-26 EC ECSENADI202267279A patent/ECSP22067279A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO2022011686A2 (es) | 2022-08-30 |
PE20221498A1 (es) | 2022-09-29 |
KR102572714B1 (ko) | 2023-08-31 |
ECSP22067279A (es) | 2022-09-30 |
MX2022010220A (es) | 2022-10-10 |
BR112022014762A2 (pt) | 2022-10-11 |
CN115087649A (zh) | 2022-09-20 |
KR20210109476A (ko) | 2021-09-06 |
CA3169604A1 (en) | 2021-09-02 |
JP2023514754A (ja) | 2023-04-07 |
JP7442663B2 (ja) | 2024-03-04 |
EP4112612A1 (en) | 2023-01-04 |
EP4112612A4 (en) | 2024-04-03 |
WO2021172955A1 (ko) | 2021-09-02 |
US20230096670A1 (en) | 2023-03-30 |
AU2021225706A1 (en) | 2022-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ594077A (en) | Process for production of delta-9-tetrahydrocannabinol | |
AR061112A1 (es) | Procedimientos para la produccion de derivados de benzopiran-2-ol, fesoterodina y un derivado de la tolterodina e intermediarios de sintesis de los citados procesos. | |
BR112019005294A2 (pt) | processo para preparar (±)-2-exo-(2-metilbenzilóxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano de fórmula (i) e método para prevenir ou reduzir a formação de depósitos no interior de um reator | |
DE502004011239D1 (de) | Verfahren zur dehydratisierung substituierter 4-dimethylamino-2-aryl-butan-2-ol-verbindungen und verfahren zur herstellung substituierter dimethyl-(3-katalyse | |
DE60316573D1 (de) | Verfahren und vorrichtung für die herstellung einer ein bituminöses bindemittel enthaltenden baumischung | |
US2445393A (en) | New amino-derivatives of dioxa-cyclopentane | |
EA202191502A1 (ru) | Способ получения апиксабана | |
CL2022002326A1 (es) | Intermedio útil para síntesis de inhibidor de sglt y método para preparar inhibidor de sglt | |
CO2023003013A2 (es) | Proceso | |
MX2020013827A (es) | Proceso de preparacion de compuestos triciclicos. | |
ATE259366T1 (de) | Herstellungsverfahren für ein bekanntes terazolderivat | |
PH12021550297A1 (en) | Preparation of intermediate useful for synthesis of sglt inhibitor | |
ATE493426T1 (de) | Herstellungsverfahren für tagatose unter anwendung einer galactoseisomerisierung mit hoher ausbeute | |
MX2018010128A (es) | Toxina nueva y metodo de preparacion de un intermediario de la misma. | |
MX2021005343A (es) | Proceso para la preparacion de isoxazolinas opticamente enriquecidas. | |
Behr et al. | Synthesis of 6-deoxy-homoDMDP and its C (5)-epimer: Absolute stereochemistry of natural products from Hyacinthus orientalis | |
BRPI0514000A (pt) | método para a produção de derivados de diarilcicloalquila | |
UY39026A (es) | Proceso químico para la síntesis de compuestos de piridazina sustituida | |
US3891681A (en) | Synthesis of steroids | |
MX2019004141A (es) | Proceso para la obtencion de los enantiomeros del praziquantel y sus derivados 4'-hidroxilados. | |
BR112023024764A2 (pt) | Compostos, processos para preparar um composto de fórmula (8c), para preparar um composto de fórmula (8a) e para preparar um composto de fórmula (9-1) e processo para fazer um composto de fórmula (10-2) | |
DE502005003019D1 (de) | Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten | |
BR112022020380A2 (pt) | Um processo e aparelho para preparar uma composição de estireno purificada a partir de matéria-prima que contém estireno | |
DE502008002407D1 (de) | Verfahren zur herstellung carbonat-terminierter verbindungen | |
FR848739A (fr) | Procédé de fabrication de persels, tels que les persulfates, par électrolyse |